These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4928934)

  • 1. Induction of interferon in human subjects by poly I:C.
    Field AK; Young CW; Krakoff IH; Tytell AA; Lampson GP; Nemes MM; Hilleman MR
    Proc Soc Exp Biol Med; 1971 Apr; 136(4):1180-6. PubMed ID: 4928934
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new combination of methotrexate and folinic acid for cancer treatment (acute leukemia and solid tumors)].
    Schwarzenberg L; Mathé G; Hayat M; de Vassal F; Amiel JL; Cattan A; Schneider M; Schlumberger JR; Rosenfeld C; Jasmin C; Ngo Minh Man
    Presse Med (1893); 1969 Mar; 77(11):385-8. PubMed ID: 4891646
    [No Abstract]   [Full Text] [Related]  

  • 3. How to use cancer chemotherapy.
    Dollinger MR
    Am Fam Physician; 1971 Jun; 3(6):73-84. PubMed ID: 4325596
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of systemic hemolymphopathies and of epithelial and connective-tissue neoplasms with a methylhydrazine derivative].
    Zarrilli D; Perrone V; Pergola M
    Clin Ter; 1966 Oct; 39(2):123-36. PubMed ID: 4871417
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of cooperative clinical studies of the antineoplastic antibiotic dactinomycin].
    Titievskaia VV; Gorbunova VA; Akopiants SM; Budkevich IuV; Kuchkarev RN
    Antibiotiki; 1972 Oct; 17(10):953-8. PubMed ID: 4348682
    [No Abstract]   [Full Text] [Related]  

  • 6. Interferon induction in cancer: with some observations on the clinical effects of poly 1:C.
    Young CW
    Med Clin North Am; 1971 May; 55(3):721-8. PubMed ID: 4932880
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of interferon in vivo by polynucleotides.
    Levy HB
    Tex Rep Biol Med; 1977; 35():91-8. PubMed ID: 616675
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytostatic therapy of hemoblastoses and malignant tumors with a methylhydrazine derivative].
    Kühböck J; Mannheimer E; Pietschmann H
    Wien Klin Wochenschr; 1966 Dec; 78(48):841-4. PubMed ID: 4291623
    [No Abstract]   [Full Text] [Related]  

  • 9. Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas.
    Mathé G; Schwarzenberg L; Pouillart P; Oldham R; Weiner R; Jasmin C; Rosenfeld C; Hayat M; Misset JL; Musset M; Schneider M; Amiel JL; De Vassal F
    Cancer; 1974 Oct; 34(4):985-92. PubMed ID: 4608026
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of cooperative clinical study of the new antineoplastic antibiotic, bruneomycin].
    Blokhin NN; Astrakhan VI; Garin AM; Lorie IuI; Blokhina NG; Voznyĭ EK; Karev NI; Kachalov VK; Kuchkarev RN; Lichinshcher MR; Moroz LV
    Antibiotiki; 1968 Sep; 13(9):771-80. PubMed ID: 4303352
    [No Abstract]   [Full Text] [Related]  

  • 11. Daunomycin in the treatment of acute leukaemia and neoplastic diseases in childhood.
    Massimo L; Fossati-Guglielmoni A; Fortuna E
    Helv Paediatr Acta; 1968 Aug; 23(4):315-33. PubMed ID: 4300437
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary results of the therapeutic effectiveness in leukemia and malignant tumors in children of a new antineoplastic antibiotic: "daunomycin"].
    Massimo L; Fossati-Guglielmoni A; Fortuna E
    Arch Ital Patol Clin Tumori; 1967; 10(1):3-19. PubMed ID: 4878269
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trials with N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride in malignant lymphoma and other disseminated neoplasia.
    Samuels ML; Leary WV; Alexanian R; Howe CD; Frei E
    Cancer; 1967 Aug; 20(8):1187-94. PubMed ID: 4291633
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of correlation between interferon induction and antitumour effect of poly I-poly C.
    Weinstein AJ; Gazdar AF; Sims HL; Levy HB
    Nat New Biol; 1971 May; 231(19):53-4. PubMed ID: 5283388
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-acting anabolic agent (clinibolin) as an adjuvant in tumor therapy].
    Kleibel F
    Munch Med Wochenschr; 1969 Nov; 111(47):2452-4. PubMed ID: 5395737
    [No Abstract]   [Full Text] [Related]  

  • 16. Initial clinical experience with vinglycinate sulfate, a molecular modification of vinblastine.
    Armstrong JG; Dyke RW; Fouts PJ; Hawthorne JJ; Jansen CJ; Peabody AM
    Cancer Res; 1967 Feb; 27(2):221-7. PubMed ID: 5335120
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immediate results of the clinical use of bruneomycin].
    Akop'iants SS
    Antibiotiki; 1968 Jan; 13(1):84-7. PubMed ID: 4873978
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)].
    Mathé G; Schwarzenberg L; Pouillart P; Weiner R; Oldham R; Jasmin C; Rosenfeld C; Hayat M; Schneider M; Amiel JL; Céoara B; Steresco-Musset M; de Vassal F
    Nouv Presse Med; 1974 Mar; 3(9):521-4. PubMed ID: 4595555
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the value of chloroquine in the treatment of malignant tumor diseases].
    Tanneberger S; Bacigalupo G
    Arch Geschwulstforsch; 1967; 29(3):266-73. PubMed ID: 4299158
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preliminary results of clinical trial of the antineoplastic antibiotic bruneomycin].
    Garim AM; Lorie IuI; Reĭzinger MA; Shkarenkov VA; Durnov LA
    Antibiotiki; 1967 Jul; 12(7):609-19. PubMed ID: 4299328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.